Metropolitan Life Insurance Company (MetLife)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,514
| Closed | -$84.7K | – | 2556 |
|
|
2023
Q1 | $84.7K | Sell |
3,514
-75
| -2% | -$1.81K | ﹤0.01% | 1092 |
|
|
2022
Q4 | $37.9K | Hold |
3,589
| – | – | ﹤0.01% | 1639 |
|
|
2022
Q3 | $16.2K | Buy |
3,589
+2,447
| +214% | +$11K | ﹤0.01% | 2123 |
|
|
2022
Q2 | $4.57K | Sell |
1,142
-2,728
| -70% | -$10.9K | ﹤0.01% | 2345 |
|
|
2022
Q1 | $28.3K | Sell |
3,870
-1,411
| -27% | -$10.3K | ﹤0.01% | 1923 |
|
|
2021
Q4 | $29.7K | Sell |
5,281
-1,243
| -19% | -$6.99K | ﹤0.01% | 2737 |
|
|
2021
Q3 | $41.8K | Sell |
6,524
-7,257
| -53% | -$46.4K | ﹤0.01% | 2784 |
|
|
2021
Q2 | $116K | Buy |
13,781
+1,525
| +12% | +$12.9K | ﹤0.01% | 2518 |
|
|
2021
Q1 | $129K | Sell |
12,256
-1,297
| -10% | -$13.6K | ﹤0.01% | 2310 |
|
|
2020
Q4 | $230K | Hold |
13,553
| – | – | ﹤0.01% | 1841 |
|
|
2020
Q3 | $174K | Hold |
13,553
| – | – | ﹤0.01% | 1859 |
|
|
2020
Q2 | $191K | Buy |
+13,553
| New | +$191K | ﹤0.01% | 1827 |
|